Daniel Ginard

2.4k total citations
50 papers, 773 citations indexed

About

Daniel Ginard is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Daniel Ginard has authored 50 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 31 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Daniel Ginard's work include Inflammatory Bowel Disease (35 papers), Microscopic Colitis (25 papers) and Autoimmune and Inflammatory Disorders (8 papers). Daniel Ginard is often cited by papers focused on Inflammatory Bowel Disease (35 papers), Microscopic Colitis (25 papers) and Autoimmune and Inflammatory Disorders (8 papers). Daniel Ginard collaborates with scholars based in Spain, Chile and United States. Daniel Ginard's co-authors include Sam Khorrami, Javier P. Gisbert, Francesc Casellas, Valle García-Sánchez, A. Obrador, Julián Panés, Eugeni Domènech, Ignacio Marín‐Jiménez, Carlos Taxonera and Albert Villòria and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and Frontiers in Microbiology.

In The Last Decade

Daniel Ginard

44 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Ginard Spain	16	471	376	200	156	142	50	773
Sam Khorrami Spain	17	176 0.4×	123 0.3×	475 2.4×	124 0.8×	97 0.7×	32	786
Bengt Curman Sweden	14	945 2.0×	797 2.1×	313 1.6×	216 1.4×	458 3.2×	20	1.5k
Frederik Trier Møller Denmark	11	214 0.5×	166 0.4×	128 0.6×	117 0.8×	96 0.7×	36	652
Todd Butler United States	7	556 1.2×	459 1.2×	188 0.9×	46 0.3×	51 0.4×	8	701
Esther García-Planella Spain	23	1.2k 2.5×	1.0k 2.8×	468 2.3×	87 0.6×	203 1.4×	67	1.5k
H. H. Gunson Nigeria	19	212 0.5×	118 0.3×	34 0.2×	222 1.4×	165 1.2×	64	1.1k
Rekha Gupta India	16	69 0.1×	112 0.3×	138 0.7×	235 1.5×	89 0.6×	59	732
Giuseppe Privitera Italy	14	274 0.6×	203 0.5×	89 0.4×	243 1.6×	196 1.4×	31	656
Rizwan Ahmed United States	13	131 0.3×	115 0.3×	82 0.4×	141 0.9×	159 1.1×	22	550
William Connell Australia	9	358 0.8×	320 0.9×	147 0.7×	108 0.7×	56 0.4×	19	526

Countries citing papers authored by Daniel Ginard

Since Specialization

Citations

This map shows the geographic impact of Daniel Ginard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ginard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ginard more than expected).

Fields of papers citing papers by Daniel Ginard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ginard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ginard. The network helps show where Daniel Ginard may publish in the future.

Co-authorship network of co-authors of Daniel Ginard

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ginard. A scholar is included among the top collaborators of Daniel Ginard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ginard. Daniel Ginard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología. 47(7). 727–733.

2.

Rodríguez–Lago, Iago, Fiorella Cañete, Claudia Herrera‐deGuise, et al.. (2024). Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study. Gastroenterología y Hepatología (English Edition). 47(7). 727–733.

3.

Marras, Carlos, Daniel Ginard, J.M. Carrascosa, et al.. (2024). An Educational Digital Tool to Improve the Implementation of Switching to a Biosimilar (Rapid Switch Trainer): Tool Development and Validation Study. JMIR Formative Research. 8. e56553–e56553.

4.

Rodríguez, Ramón María Alvargonzález, et al.. (2024). Lipid signature associated with chronic colon inflammation reveals a dysregulation in colonocyte differentiation process. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(7). 159528–159528. 6 indexed citations

5.

Montero, David A., Pablo Gallardo, Mauricio J. Farfán, et al.. (2021). Landscapes and bacterial signatures of mucosa-associated intestinal microbiota in Chilean and Spanish patients with inflammatory bowel disease. Microbial Cell. 8(9). 223–238. 17 indexed citations

6.

Ginard, Daniel, Ignacio Marín‐Jiménez, Manuel Barreiro‐de Acosta, et al.. (2020). Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis. Gastroenterología y Hepatología (English Edition). 43(2). 97–105. 1 indexed citations

7.

Ginard, Daniel, Ignacio Marín‐Jiménez, Manuel Barreiro‐de Acosta, et al.. (2019). Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento tópico en la colitis ulcerosa. Gastroenterología y Hepatología. 43(2). 97–105. 1 indexed citations

8.

Rodríguez–Lago, Iago, J M Benítez, Valle García–Sánchez, et al.. (2018). Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients’ point of view. Gastroenterología y Hepatología. 41(7). 423–431. 11 indexed citations

9.

Céspedes, Sandra, Felipe Del Canto, Marjorie De la Fuente, et al.. (2017). Genetic Diversity and Virulence Determinants of Escherichia coli Strains Isolated from Patients with Crohn's Disease in Spain and Chile. Frontiers in Microbiology. 8. 639–639. 34 indexed citations

10.

Khorrami, Sam, Daniel Ginard, Ignacio Marín‐Jiménez, et al.. (2016). Ustekinumab for the Treatment of Refractory Crohnʼs Disease. Inflammatory Bowel Diseases. 22(7). 1662–1669. 124 indexed citations

11.

Casellas, Francesc, Daniel Ginard, & Sabino Riestra. (2016). Patient satisfaction in the management of mild-to-moderate ulcerative colitis: Results of a Delphi study among patients and physicians. Digestive and Liver Disease. 48(10). 1172–1179. 6 indexed citations

12.

Ginard, Daniel, Sam Khorrami, Ignacio Marı́n, et al.. (2012). P252 Effectiveness and safety of ustekinumab as rescue therapy in multi-drug resistant Crohn's disease. Journal of Crohn s and Colitis. 6. S109–S110. 2 indexed citations

13.

Casellas, Francesc, Daniel Ginard, Isabel Vera, & Antonio Torrejón. (2012). Satisfaction of health care professionals managing patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 7(7). e249–e255. 8 indexed citations

14.

Domènech, Eugeni, Yamile Zabana, E. García‐Planella, et al.. (2009). Clinical outcome of newly diagnosed Crohn’s disease: a comparative, retrospective study before and after infliximab availability. Alimentary Pharmacology & Therapeutics. 31(2). 233–239. 19 indexed citations

15.

Taxonera, Carlos, Luı́s Rodrigo, Francesc Casellas, et al.. (2009). Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in Patients With Luminal or Fistulizing Crohn's Disease. Journal of Clinical Gastroenterology. 43(10). 950–956. 22 indexed citations

16.

Loras, Carme, Cristina Morales Saro, Ferrán Gónzalez‐Huix, et al.. (2008). Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study. The American Journal of Gastroenterology. 104(1). 57–63. 108 indexed citations

17.

Ginard, Daniel & Zoe Mariñó. (2008). ¿Tengo que premedicar a todos los pacientes cuando les pongo infliximab para disminuir las reacciones infusionales y/o la inmunogenicidad?. Gastroenterología y Hepatología. 31(8). 542–543. 1 indexed citations

18.

Panés, Julián, M. Guilera, Daniel Ginard, et al.. (2007). Treatment cost of ulcerative colitis. Digestive and Liver Disease. 39(7). 617–625. 30 indexed citations

19.

Obrador, A., et al.. (2006). Review article: colorectal cancer surveillance in ulcerative colitis – what should we be doing?. Alimentary Pharmacology & Therapeutics. 24(s3). 56–63. 26 indexed citations

20.

Reyes, José, et al.. (2002). Abordaje endoscópico de los cuerpos extraños esofágicos. Resultados de una serie retrospectiva de 501 casos. Gastroenterología y Hepatología. 25(7). 448–451. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact